Today: 29 June 2026
Snap shares claw back some losses ahead of another big test Monday
17 May 2026
2 mins read

Snap shares claw back some losses ahead of another big test Monday

New York, May 17, 2026, 15:03 (EDT)

  • Snap closed at $5.53 on Friday, up 3.17%. Shares are down about 9% from May 8, when they ended the day at $6.08.
  • The NYSE is open for trading Monday to Friday between 9:30 a.m. and 4:00 p.m. in New York. The exchange stays closed on Sundays.
  • Investors face a legal settlement from Friday, soft signs in the ad market, and a new cost-cutting push at Snap as the week begins.

Snap Inc. (SNAP) traded under pressure going into Monday, holding most of Friday’s bounce. The company has struggled with soft ad demand and legal troubles. Investors remain wary that recent layoffs will turn the bottom line around.

The stock added 3.17% Friday to finish at $5.53, even as the rest of the market had trouble. But the stock was still off about 9% for the week, after closing last week at $6.08, according to historical price data. About 37.8 million shares changed hands on Friday.

The market shuts on Sunday. On Monday, trading picks up for the first full session since the latest legal headlines and last week’s risk-off close in U.S. stocks. The NYSE starts at 9:30 a.m. Eastern and finishes at 4:00 p.m., sticking to its standard hours.

YouTube, Snap, and TikTok reached settlements with a Kentucky school district late Friday, Reuters reported. The case was set to be the first trial over claims that social media sites fueled a youth mental health crisis. No settlement terms were disclosed. Snap described the resolution as amicable. Meta Platforms still faces trial June 15 in the same court.

Snap shares are still moving after earnings and now a settlement is in play. First-quarter revenue hit $1.529 billion, up 12%. Daily active users came in at 483 million, a 5% jump. Adjusted EBITDA was $233 million, more than double last year.

Snap CEO Evan Spiegel says the company will keep its “disciplined execution” approach while investing in Specs, AR glasses, and what he calls “intelligent eyewear.” Bulls see this as a smaller, more focused Snap with better cash flow and a bet on hardware and AI over the long haul. Snap Inc. Investor Relations

Snap’s ad revenue is barely up, with Reuters reporting just a 3% increase to $1.24 billion for the quarter. The company said the Middle East conflict in March hit results by $20 million to $25 million. Snap also scrapped its $400 million Perplexity AI deal. Q2 revenue guidance is $1.52 billion to $1.55 billion, about in line with what most analysts expected.

Snap’s ad business remains under pressure. Meta, Pinterest and Reddit saw Q1 revenue climb, according to Reuters, and analysts say smaller players like Snap risk missing out as advertisers shift dollars to bigger names such as Meta and Google. Snap is working on growing subscriptions and direct-response ads — the kind aimed at driving app installs or purchases — to capture more spend.

Snap is tightening spending again. Back in April, the company announced plans to cut around 1,000 jobs—roughly 16% of staff—and close more than 300 vacancies. CEO Spiegel said annualized costs would fall by over $500 million in the second half.

Snap’s cost cuts might give investors something, but big concerns remain. Russ Mould at AJ Bell told Reuters the cuts may help, but the real question is whether Snap has “a defensible business model and competitive position.” There is risk on Monday that ad demand stays weak, more legal threats crop up, and Snap’s Specs could keep burning cash while failing to deliver. Reuters

Snap shares struggled with the market moving lower. The S&P 500 dropped 1.24% Friday. The Nasdaq lost 1.54%. The Dow finished down 1.07%. Oil and Treasury yields moved higher as traders took profits after gains in AI names. The Nasdaq’s six-week run ended.

Snap is bracing for a rough patch next week. Shares got a lift late Friday, which set something of a floor, but no real shift in direction yet. Traders are watching what happens after the social-media litigation settlement and looking for signs on North American ad demand. The bounce came through, but the trend still isn’t there.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • UK's Scancell proposes reverse merger with Nasdaq-listed Neuphoria to boost US investor presence
    June 29, 2026, 10:20 AM EDT. UK-based biotech Scancell Holdings has proposed a reverse merger with Neuphoria Therapeutics, listed on Nasdaq, to secure a U.S. listing and enhance its profile among American specialist investors. The all-stock deal details remain undisclosed. Neuphoria's shares have steeply declined after its lead drug soclenicant failed a late-stage social anxiety trial, prompting a strategic review and suitor interest, including offers from hedge fund Lynx1 Master Fund. Neuphoria maintains a partnership with Merck, with potential milestone revenues of up to $450 million. Meanwhile, Scancell aims to advance its own melanoma and cancer vaccine candidates, seeking equity and debt financing for its phase 3 studies. The deal appears driven more by Scancell's desire for Nasdaq access than Neuphoria's pipeline assets.
Tesla Stock Gets a Weekend Shock as Model Y Prices Rise After Friday Slide
Previous Story

Tesla Stock Gets a Weekend Shock as Model Y Prices Rise After Friday Slide

QuantumScape Stock Ends Volatile Week Down; Bulls Still Looking for Key Catalyst
Next Story

QuantumScape Stock Ends Volatile Week Down; Bulls Still Looking for Key Catalyst

Go toTop